The global breast biopsy market is anticipated to grow at a steady CAGR of 5.5% during the forecast period 2020-2026, according to a report by Gen Consulting Company.

The global Breast Biopsy Devices Market is projected to be valued at USD 2.47 billion in 2025 and is expected to reach USD 4.21 billion by 2035, registering a CAGR of 5.5% during the forecast period.

GeneCentric Therapeutics has secured $8m in new funding to accelerate the development of its RNA-based liquid biopsy platform.

In addition to being faster and less invasive than a traditional tissue biopsy, the blood test is also potentially more ...

A patch containing tens of millions of microscopic nanoneedles could soon replace traditional biopsies, scientists have found ...

For diagnostic accuracy, HPV WGS demonstrated statistically significant superiority versus ddPCR (0.99 vs 0.90), HPV antibody testing (0.83), and clinical workup (0.82).

The global Cancer Biopsy Market encompasses a wide array of diagnostic tools—from traditional tissue biopsy needles and core ...

A liquid biopsy is a blood test that more and more oncologists are using to help detect and treat lung cancer. Learn about ...

A traditional tissue biopsy comes with risks and challenges—the target area can be hard to reach and bleeding and pain can last up to a month afterward. Patients can expect steep medical bills ...

Endoscopy allows for tissue biopsy for histopathological examination, aiding in the accurate diagnosis of malignancies and determination of tumor stage and grade. Hower, endoscopic examinations such ...

The latter CPU only has eight P-Cores, with 16 lower-power E-Cores (where E stands for "efficiency") pushing up the total to 24. However, it's the eight P-Cores that make the Core i9 14900K the ...